403
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patient engagement in research: lessons learned from CAPTURE ALS, a longitudinal observational ALS study

, , , , , & show all
Received 06 Dec 2023, Accepted 04 Mar 2024, Published online: 22 Mar 2024

References

  • Picher-Martel V, Magnussen C, Blais M, Bubela T, Das S, Dionne A, et al. CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:33–9.
  • Harrington RL, Hanna ML, Oehrlein EM, Camp R, Wheeler R, Cooblall C, et al. Defining patient engagement in research: results of a systematic review and analysis: report of the ISPOR patient-centered special interest group. Value Health. 2020; Jun 123:677–88.
  • Aubin D, Hebert M, Eurich D. The importance of measuring the impact of patient-oriented research. Cmaj. 2019; Aug 6191:E860–E864.
  • Esmail L, Moore E, Rein A. Evaluating patient and stakeholder engagement in research: moving from theory to practice. J Comp Eff Res. 2015; Mar4:133–45.
  • Gradinger F, Britten N, Wyatt K, Froggatt K, Gibson A, Jacoby A, et al. Values associated with public involvement in health and social care research: a narrative review. Health Expect. 2015;18:661–75.
  • Childerhose JE, Finnila CH, Yu JH, Koenig BA, McEwen J, Berg SL, et al. Participant engagement in translational genomic research: respect for persons—and then some. Ethics Hum Res. 2019; Sep41:2–15.
  • Fox G, Fergusson DA, Daham Z, Youssef M, Foster M, Poole E, et al. Patient engagement in preclinical laboratory research: a scoping review. eBioMedicine [Internet]. 2021 Aug 1 [cited 2023 Jan 12];70. Available from: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00277-2/fulltext
  • Ochieng CA, Minion JT, Turner A, Blell M, Murtagh MJ. What does engagement mean to participants in longitudinal cohort studies? A qualitative study. BMC Med Ethics. 2021; Jun 2422:77.
  • Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014;17:637–50.
  • Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014; Feb 2614:89.
  • Forsythe LP, Carman KL, Szydlowski V, Fayish L, Davidson L, Hickam DH, et al. Patient engagement in research: early findings from the Patient-Centered Outcomes Research Institute. Health Aff (Millwood). 2019; Mar38:359–67.
  • Musson LS, McDermott CJ, Hobson EV. Exploring patient and public involvement in motor neuron disease research. Amyotroph Lateral Scler Frontotemporal Degener. 2019; Oct 220:511–20.
  • Mader LB, Harris T, Kläger S, Wilkinson IB, Hiemstra TF. Inverting the patient involvement paradigm: defining patient led research. Res Involv Engagem. 2018; Jul 104:21.
  • Poleshuck E, Wittink M, Crean H, Gellasch T, Sandler M, Bell E, et al. Using patient engagement in the design and rationale of a trial for women with depression in obstetrics and gynecology practices. Contemp Clin Trials. 2015; Jul 143:83–92.
  • Berry JD, Bedlack R, Mathews D, Agnese W, Apple S. Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker study. Amyotroph Lateral Scler Frontotemporal Degener. 2021; Jan 222:147–50.
  • Calderwood L, Brown M, Gilbert E, Wong E. Innovations in participant engagement and tracking in longitudinal surveys. In: Advances in Longitudinal Survey Methodology [Internet]. John Wiley & Sons, Ltd; 2021 [cited 2022 Jun 2]. p. 47–73. Available from: http://onlinelibrary.wiley.com/doi/abs/10.1002/9781119376965.ch3
  • Edwards V, Wyatt K, Logan S, Britten N. Consulting parents about the design of a randomized controlled trial of osteopathy for children with cerebral palsy. Health Expect. 2011;14:429–38.
  • Planner C, Bower P, Donnelly A, Gillies K, Turner K, Young B. Trials need participants but not their feedback? A scoping review of published papers on the measurement of participant experience of taking part in clinical trials. Trials 2019; Jun 2420:381.
  • Government of Canada CI of HR. Strategy for Patient-Oriented Research [Internet]. 2018 [cited 2022 May 31]. Available from: https://cihr-irsc.gc.ca/e/41204.html
  • NIHR. NIHR, National Institute for Health and Care Research. 2021 [cited 2023 Jan 11]. Briefing notes for researchers - public involvement in NHS, health and social care research. Available from: https://www.nihr.ac.uk/documents/briefing-notes-for-researchers-public-involvement-in-nhs-health-and-social-care-research/27371
  • Garcia M, Luecke E, Mayo AJ, Scheckter R, Ndase P, Kiweewa FM, et al. Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study. BMC Public Health. 2021;21:2041.
  • Park A, Calderwood L, Wong E. Participant engagement in longitudinal studies: current practice, opportunities and challenges. Soc Res Pract. 2019;7:1–13.
  • Siddiqi B, Gibaldi J. Retention strategies for keeping participants engaged. Appl Clin Trials 2019; Aug 3128:20–1.
  • Barn P, Rideout KL, Lo W, Josey D, Vint Z, Sha C, et al. Better together: Launching and nurturing a community stakeholder committee to enhance care and research for asthma and COPD. Chest 2022; Feb 1161:382–8.
  • Green G, Johns T. Exploring the relationship (and power dynamic) between researchers and public partners working together in applied health research teams. Front Sociol [Internet]. 2019 [cited 2020 Sep 10];4. Available from: https://www.frontiersin.org/articles/10.3389/fsoc.2019.00020/full
  • van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, et al. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 2019; Apr 292:e1610–23–e1623.
  • ALS Society of Canada. ALS Society of Canada. [cited 2023 Feb 2]. Ambassadors. Available from: https://als.ca/get-involved/volunteer/ambassadors/
  • Bedlack R, Pogemiller A, Shefner J, Cudkowicz M, Heiman-Patterson T. ALS clinical research learning institutes (ALS-CRLI): empowering people with ALS to be research ambassadors. Amyotroph Lateral Scler Frontotemporal Degener. 2020; Apr 221:216–21.
  • Andrews JA, Bruijn LI, Shefner JM. ALS drug development guidances and trial guidelines: Consensus and opportunities for alignment. [Review]. Neurology 2019;93:66–71.
  • Raz AE, Schneid I, Carmi E, Kedem O, Lerner B. Engaging patients in identifying risk factors for ALS. SSM - Qual Res Health. 2022; Dec 12:100179.
  • Howe A, Mathie E, Munday D, Cowe M, Goodman C, Keenan J, et al. Learning to work together – lessons from a reflective analysis of a research project on public involvement. Res Involv Engagem. 2017; Jan 93:(1. 1.
  • Manafo E, Petermann L, Mason-Lai P, Vandall-Walker V. Patient engagement in Canada: a scoping review of the ‘how’ and ‘what’ of patient engagement in health research. Health Res Policy Syst. 2018;16:5. Feb 7 [cited 2019 Mar 20]Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804082/
  • International Association for Public Participation. iap2 International Association for Public Participation. [cited 2023 Jan 10]. IAP2 Resources - International Association for Public Participation. Available from: https://www.iap2.org/page/resources
  • Organizing Engagement [Internet]. 2019 [cited 2024 Jan 31]. Spectrum of Public Participation. Available from: https://organizingengagement.org/models/spectrum-of-public-participation/
  • Bammer G. Key issues in co-creation with stakeholders when research problems are complex. Evid Policy. 2019; Aug 115:423–35.
  • Beck M, Frank B, Minaeian S, Nicholls SG. Decision-making about newborn screening panels in Canada: Risk management and public participation. In: Gattinger M, editor. Democratizing risk governance: bridging science, expertise, deliberation and public values [Internet]. Cham, Switzerland: Springer Nature; 2023. p. 217–43. Available from: https://doi.org/10.1007/978-3-031-24271-7
  • Holcomb J, Ferguson GM, Sun J, Walton GH, Highfield L. Stakeholder engagement in adoption, implementation, and sustainment of an evidence-based intervention to increase mammography adherence among low-income women. J Cancer Educ. 2022; Oct 137:1486–95.
  • ALS Society of Canada [Internet]. [cited 2023 Aug 31]. ALS Canada. Available from: https://als.ca/
  • itracks [Internet]. [cited 2021 Oct 19]. itracks. Available from: https://www.itracks.com/
  • Genuis SK, Luth W, Weber G, Bubela T, Johnston WS. Asynchronous online focus groups for research with people living with amyotrophic lateral sclerosis and family caregivers: usefulness, acceptability and lessons learned. BMC Med Res Methodol. 2023; Oct 623:222.
  • Genuis SK, Luth W, Bubela T, Johnston WS. What do people affected by amyotrophic lateral sclerosis want from health communications? Evidence from the ALS Talk Project. Muscle Nerve. 2023;68:286–95.
  • Miles M, Huberman M, Saldana J. Qualitative data analysis: a methods sourcebook. 4th edition. Los Angeles London New Delhi Singapore Washington DC Melbourne: Sage Publications; 2019. 408 p.
  • Cobb EM, Meurer W, Harney D, Silbergleit R, Lake BP, Clark C, et al. Patient engagement in neurological clinical trials design: A conference summary. Clin Transl Sci. 2015; Dec8:776–8.
  • Johnston W, Magnussen C, Vande Velde C, Luth W, Participant Partner Advisory Council, Genuis SK. Operationalizing meaningful participant engagement in ALS research: Early lessons from CAPTURE ALS. Amyotroph Lateral Scler Front Degener 2022;23:144.
  • Hamilton CB, Hoens AM, Backman CL, McKinnon AM, McQuitty S, English K, et al. An empirically based conceptual framework for fostering meaningful patient engagement in research. Health Expect. 2018; Feb21:396–406.
  • Meet the Team – Capture ALS [Internet]. [cited 2023 Oct 11]. Available from: https://captureals.ca/meet-the-team/
  • Dudley L, Gamble C, Preston J, Buck D, Hanley B, Williamson P, et al. What difference does patient and public involvement make and what are its pathways to impact? Qualitative study of patients and researchers from a cohort of randomised clinical trials. PLoS One. 2015; Jun 810:e0128817.
  • Ocloo J, Matthews R. From tokenism to empowerment: progressing patient and public involvement in healthcare improvement. BMJ Qual Saf. 2016; Aug 125:626–32.
  • de Wit MPT, Elberse JE, Broerse JEW, Abma TA. Do not forget the professional – the value of the FIRST model for guiding the structural involvement of patients in rheumatology research. Health Expect. 2015; Aug18:489–503.
  • Duffett L. Patient engagement: What partnering with patient in research is all about. Thromb Res. 2017; Feb150:113–20.
  • Chiò A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, et al. ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology 2011; Oct77:1432–7.
  • van Eijk RPA, Westeneng HJ, Nikolakopoulos S, Verhagen IE, van Es MA, Eijkemans MJC, et al. Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials. Neurology 2019; Jan 2992:e451–60–e460.
  • Wilson P, Mathie E, Keenan J, McNeilly E, Goodman C, Howe A, et al. ReseArch with Patient and Public invOlvement: a RealisT evaluation – the RAPPORT study [Internet]. NIHR Journals Library; 2015 [cited 2023 Jan 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK315999/
  • Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis. Neurol Clin Pract. 2013; Aug3:313–20.
  • Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017; Oct 53:17071.
  • Aoun SM, Bentley B, Funk L, Toye C, Grande G, Stajduhar KJ. A 10-year literature review of family caregiving for motor neurone disease: Moving from caregiver burden studies to palliative care interventions. Palliat Med. 2013; May 127:437–46.
  • Galvin M, Carney S, Corr B, Mays I, Pender N, Hardiman O. Needs of informal caregivers across the caregiving course in amyotrophic lateral sclerosis: a qualitative analysis. BMJ Open. 2018; Jan 278:e018721.
  • Crocker JC, Ricci-Cabello I, Parker A, Hirst JA, Chant A, Petit-Zeman S, et al. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. Bmj. 2018; Nov 28363:k4738.
  • Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2015; Mar16:65–71.
  • Needham J, Taylor J, Nomikos D. Integrating patient-centred research in the Canadian cancer trials group. Curr Oncol. 2021; Jan 2128:630–9.
  • Fournier CN. Considerations for amyotrophic lateral sclerosis (ALS) clinical trial design. Neurotherapeutics. 2022; Jul 119:1180–92.